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High quality integrated post-cardiac arrest care can significantly influence the outcome of pa-
tients with cardiac arrest, especially neurological recovery, and numerous studies have been 
conducted on this topic. In the 2015 Korean cardiopulmonary resuscitation (CPR) guidelines, 
post-cardiac arrest care was emphasized with effective advanced life support as one of the es-
sential chains for survival. Based on an in-depth scientific evidence review using a standardized 
methodological approach proposed by the GRADE (Grading of Recommendations Assessment, 
Development, and Evaluation) working group, the guidelines either partially updated the recom-
mendations or added new recommendations for each specific topic.
POST-CARDIAC ARREST CARE STRATEGIES (Fig. 1 and Table 1)
1. Airway and breathing
When a patient is unconscious after the return of spontaneous circulation (ROSC), the airway 
should be secured by tracheal intubation, and this should be confirmed by measuring the end-
tidal carbon dioxide (ETCO2) and oxygen saturation (SpO2) levels using waveform capnography 
and pulse oximetry; additionally, mechanical ventilation should be performed while continuously 
monitoring the ETCO2 and SpO2. To avoid hypoxia, it is reasonable to use the highest available 
oxygen concentration until appropriate monitoring is available to evaluate the arterial oxygen 
tension (PaCO2) or arterial oxygen saturation (SaO2) levels. When resources are available to ti-
trate the fraction of inspired oxygen (FiO2) and monitor the saturation, it is reasonable to de-
crease the FiO2, provided that the SaO2 level can be maintained at the target range. 
 A study based on a registry reported that hyperoxia within 24 hours after ROSC was associat-
ed with a poor outcome compared to hypoxemia or normoxemia within 24 hours.1 In another 
study, hyperoxia was shown to have a dose-dependent relationship with poor outcomes, rather 
than with a certain threshold level.2 In addition, hyperoxia was associated with poor prognosis in 
a study of patients with cardiac arrest who had received mild therapeutic hypothermia.3 In con-
trast, a study of approximately 12,000 patients with cardiac arrest reported that there was no 
association between hyperoxia and mortality after the inspired oxygen level and disease severity 
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were adjusted.4 A meta-analysis of 14 observational studies 
showed significant heterogeneity across studies.5 Therefore, it is 
suggested to maintain the SaO2 at a level of 94% to 98% to 
avoid hypoxemia and the potential risk of hyperoxia.
 Hypocapnia causes cerebral vasoconstriction, and it reduces ce-
rebral blood flow.6 Observational studies using a registry of patients 
with cardiac arrest have reported an association between hypo-
capnia and poor neurologic outcome.7,8 Two observational studies 
reported that mild hypercapnia was associated with more favor-
able neurologic outcomes in patients with cardiac arrest in inten-
sive care units.7,9 However, several other studies did not show a con-
sistent association between hypercapnia and outcome.7-10 There-
fore, it is suggested to maintain the CO2 level within a normal physi-
ological range (PaCO2 35 to 45 mmHg or ETCO2 30 to 40 mmHg).
2. Circulation
1) Hemodynamic stabilization
Post-cardiac arrest patients are often hemodynamically unstable 
due to the underlying etiology of arrest, myocardial dysfunction, 
and systemic ischemia/reperfusion response.11 Therefore, immedi-
ately after ROSC, an arterial catheter should be promptly inserted, 
and the arterial blood pressure should be monitored continuously. 
If an arterial catheter cannot be inserted, the blood pressure should 
be frequently measured noninvasively until the patient becomes 
hemodynamically stable. Dobutamine can be helpful for post-
cardiac arrest myocardial dysfunction.12 In addition, vasodilation 
occurs due to the systemic ischemia/reperfusion response; thus, 
dopamine or norepinephrine may be needed, and intravenous flu-
ids can be an effective treatment depending on the situation.11 If 
Fig. 1. Post-cardiac arrest care algorithm. SpO2, oxygen saturation; PaCO2, arterial oxygen tension; PETCO2, partial pressure of end-tidal carbon dioxide; 
ECG, electrocardiography; IV, intravenous; SBP, systolic blood pressure; MAP, mean arterial pressure; PCI, percutaneous coronary intervention; STEMI, ST-
elevation myocardial infarction; ACS, acute coronary syndrome.
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both of which reported that using a bundle of care, including a 
hemodynamic goal, was not associated with the neurologic out-
come.17,18 In contrast, other studies have found that a bundle of 
care that included a blood pressure goal improved the neurologic 
outcome. Two prospective observational studies have reported 
that maintaining a MAP >65 mmHg improved the neurologic 
outcome, and an additional study demonstrated that the neuro-
logic outcome was better in the patient group who maintained a 
MAP >100 mmHg at 2 hours after ROSC, suggesting an associa-
tion between MAP and the neurological outcome.19-21 Yet, anoth-
er study reported that in patients with a good neurologic out-
come, maintaining the time-weighted MAP over 70 mmHg was 
associated with the neurologic outcome.22 Two before-and-after 
observational studies have investigated the effect of using a bun-
dle of care on the survival rate. Both of these studies used a bun-
dle with a MAP >80 mmHg and >65 mmHg as a goal, but there 
was no significant difference in the survival rate.17,20
 Thus, the evidence is insufficient to determine a specific he-
modynamic goal for post-cardiac arrest care. It is suggested that 
hypotension (SBP <90 mmHg or MAP <65 mmHg) should be 
immediately corrected, and a hemodynamic goal should be de-
termined for individual patients, while maintaining an SBP >100 
mmHg.
2) Evaluation and treatment of reversible causes
After ROSC and during CPR, the resuscitation team should make 
efforts to evaluate the reversible causes of cardiac arrest (i.e., the 
five H’s and five T’s: hypovolemia, hypoxia, hydrogen ions [acido-
sis], hyper/hypokalemia, hypothermia, thromboembolism, throm-
bosis, tension pneumothorax, cardiac tamponade, and tablets) 
and then treat the patient.
(1) Intervention of acute coronary syndromes
Acute coronary syndromes are a common cause of adult out-of-
hospital cardiac arrest (OHCA) with no obvious extracardiac cause 
of arrest.23,24 Thus, a 12-lead electrocardiography (ECG) and a 
cardiac marker test should be obtained as soon as possible after 
ROSC to confirm the presence or absence of acute coronary syn-
dromes.25,26 Coronary angiography should be performed emer-
gently for patients with OHCA with suspected cardiac etiology 
and ST elevation on ECG, regardless of whether the patient is 
conscious.27-29 If acute coronary syndromes are highly suspected 
in patients with OHCA with suspected cardiac etiology but their 
ECG does not show ST elevation after ROSC, early coronary angi-
ography should be considered, regardless of the consciousness 
status.30,31
Table 1. The strategies in adult immediate post-cardiac arrest care
Strategy Doses/details
Airway Consider tracheal intubation and waveform  
capnography
Breathing-oxygenation Avoid hypoxemia
Goal: titrate FiO2 to achieve SpO2 94% to 98%
Breathing-ventilation Avoid excessive ventilation
Goal: titrate to target PaCO2 35 to 45 mmHg or 
PETCO2 30 to 40 mmHg
Circulation-hemodynamics Avoiding and immediately correcting hypotension 
(systolic blood pressure <90 mmHg, mean arte-
rial pressure <65 mmHg)
Goal: systolic blood pressure ≥100 mmHg
Circulation-vasoactive drugs Norepinephrine: 0.1 to 0.5 mcg/kg/min
Dopamine: 5 to 10 mcg/kg/min
Epinephrine: 0.1 to 0.5 mcg/kg/min
Correct the reversible causes Hypovolemia, hypoxia, hydrogen ion (acidosis), 
hypokalemia/hyperkalemia, hypothermia, ten-
sion pneumothorax, cardiac tamponade, toxins, 
pulmonary thrombosis, coronary thrombosis
FiO2, fraction of inspired oxygen; SpO2, oxygen saturation; PaCO2, arterial oxygen 
tension; PETCO2, Partial pressure of end-tidal carbon dioxide.
hemodynamic instability persists even with the infusion of intra-
venous fluids or vasoactive drugs, a mechanical circulatory assis-
tance device should be considered.13
 Although there are observational studies of patients with car-
diac arrest that have investigated the relationship between blood 
pressure and outcome, a controlled study has not been conducted 
on a target goal of blood pressure. An observational study exam-
ined whether treatment with a specific hemodynamic goal (e.g., a 
mean arterial pressure [MAP] >65 mmHg) would improve neuro-
logic and functional outcome compared to treatment without a 
specific hemodynamic goal. The study reported that the mortality 
rate was higher and the functional recovery was lower in the pa-
tient group whose systolic blood pressure (SBP) was <90 mmHg 
after CPR compared to other patient groups whose SBP was ≥90 
mmHg.14 Two retrospective studies reported that the survival rate 
decreased in patients who maintained an SBP <90 mmHg and 
<100 mmHg.15,16 As several before-and-after studies have imple-
mented a bundle of care, which included a blood pressure goal, 
the effect of blood pressure cannot be evaluated alone. Moreover, 
different studies have shown different results regarding a specific 
level of blood pressure, and the level of evidence from existing 
studies is insufficient to determine a target blood pressure goal.
 Seven studies have investigated the effect of a bundle of care 
on neurologic outcome, and they reported different results. Some 
studies have found no association between a specific target blood 
pressure and neurologic outcome. In one of the studies, a MAP 
>80 mmHg was a goal, and in another study, an intervention 
was performed when a goal of MAP was below 75 mmHg, and 
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(2) Treatment of pulmonary embolism
When cardiac arrest due to pulmonary embolism is strongly sus-
pected, chest computed tomography (CT) should be performed, if 
possible. If cardiac arrest due to pulmonary embolism is confirmed, 
thrombolytics can be administered, or surgical or percutaneous 
embolectomy can be performed.32-34
TREATMENTS FOR OPTIMIZING NEUROLOG-
ICAL RECOVERY
1. Temperature control
1) Prevention and treatment of hyperpyrexia
Observational studies have reported an association between poor 
outcome and fever after ROSC in patients without targeted tem-
perature management (TTM).35,36 Hyperpyrexia occurs in many 
patients after TTM. However, the optimal approach to subsequent 
TTM remains unknown. Several studies have reported conflicting 
conclusions regarding the association with outcome.36-38 Although 
the effect of hyperpyrexia on the outcome of post-cardiac arrest 
patients is not proven, a poor outcome was associated with hy-
perpyrexia in comatose patients in whom cerebral damage was 
due to other causes such as cerebral hemorrhage or infarct, and 
it is relatively easy to treat or prevent hyperthermia.39,40 Therefore, 
it is suggested to continuously prevent or treat fever in adult co-
matose patients after ROSC from cardiac arrest, regardless of whe-
ther the patient received TTM.
2) TTM
(1) Indications and target temperature
One randomized controlled trial (RCT) and a pseudo-randomized 
trial demonstrated that TTM of 32°C to 34°C improved the neu-
rological outcome at hospital discharge and at 6 months in adult 
patients with OHCA with a shockable cardiac rhythm.41,42 There-
fore, OHCA with a shockable rhythm is a main indication for TTM. 
Regarding patients with OHCA with a non-shockable rhythm, no 
RCT was available. In a cohort study with a very low level of evi-
dence, there was an association between mild induced hypother-
mia and 6-month survival in patients with OHCA with a non-
shockable rhythm. However, a meta-analysis of two other cohort 
studies did not determine an association between mild induced 
hypothermia (32°C to 34°C) and an improvement in neurological 
results.43-46 For patients with in-hospital cardiac arrest, no RCT 
has been published. A retrospective cohort study of 1,836 patients 
found no association between mild induced hypothermia and 
survival or a functionally favorable status at hospital discharge.47 
However, in this study, the implementation rate of TTM was very 
low, and the overall outcome of patients treated without TTM 
was poor; therefore, the aggressive implementation of TTM be-
came necessary. Additionally, ultra-mild hypothermia (36°C) has 
been suggested as another target temperature since a large, well-
conducted RCT compared the target temperature levels of 33°C 
and 36°C, as it found that the neurological outcome and survival 
at 6 months after ROSC were not improved when the tempera-
ture was controlled at 36°C versus 33°C.48
 Based on the scientific evidence, regardless of the initial rhythm 
for TTM, it is recommended to select and maintain a constant 
temperature between 32°C and 36°C in adult patients with car-
diac arrest who do not show a meaningful response to verbal 
commands after ROSC. When making this recommendation, the 
writing group considered the characteristics of the cardiac arrest 
population in Korea and that pulseless electrical activity or asys-
tole (i.e., a non-shockable cardiac rhythm) is relatively more fre-
quently observed as the initial arrest rhythm. However, it is un-
known whether TTM with mild induced hypothermia (32°C to 
34°C) or ultra-mild hypothermia (36°C) is helpful to specific sub-
groups with cardiac arrest, thus additional studies are needed to 
shed light on this issue.
(2) Initiation and duration of TTM
Neuronal injury following transient global brain ischemia/reper-
fusion progresses for several days in a complex biochemical cas-
cade. Mild induced hypothermia influences various stages during 
the process.49,50 In particular, oxidative stress, increased excitatory 
amino acids, and energy depletion occur immediately after ROSC 
and during cardiac arrest. Theoretically, it would be helpful if mild 
hypothermia is induced in patients with cardiac arrest as quickly 
as possible.51,52 For this reason, several studies have compared the 
prehospital induction of hypothermia and hospital induction of 
hypothermia. In all seven RCTs with a medium level of evidence, 
there was no significant difference between the groups in terms 
of a poor neurologic outcome or mortality.53-59 A meta-analysis of 
seven studies also did not show differences in the mortality rate 
or poor neurologic outcome between the groups at hospital dis-
charge.46 Accordingly, based on current scientific evidence, it can-
not be concluded that the prehospital induction of TTM is better 
than induction at the hospital; hence, more conclusive follow-up 
studies are needed.
 A high quality interventional study is not yet available with 
which to determine an optimal duration of TTM after cardiac ar-
rest. Therefore, based on the duration used in two of the largest 
aforementioned RCTs, it is reasonable to maintain TTM for at least 
24 hours after achieving the target temperature.41,48
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(3) Methods of inducing and/or maintaining TTM
Diverse cooling methods are used to induce and maintain a tar-
get temperature, but there is no one best method. External sur-
face cooling methods used widely in the past (e.g., a cooling blan-
ket, ice packs, and a wet towel) are easy and convenient to use. 
However, they take longer to lower the patient’s core tempera-
ture, and they are difficult to maintain at a constant level, which 
adds to the medical staff’s high workload. Recently, body temper-
ature control has become easier, as cooling equipment that use 
endovascular catheters and external cooling equipment that reg-
ulates temperature with an auto-feedback system have become 
available, but they are expensive. Hence, medical staff that plan 
to perform TTM should consider a variety of factors (e.g., the place 
to initiate the treatment, staff’s ability and experience, speed in 
induction, stability during maintenance and rewarming, mobility 
of the equipment, adverse events associated with specific equip-
ment or techniques, convenience of using the equipment, cost, 
etc.), and the most optimal cooling technique should be chosen 
for individual patients.60
 Cold crystalloid intravenous fluid infusion is relatively easy to 
induce hypothermia, and it has been widely used in prehospital 
settings or during resuscitation for convenience. However, ac-
cording to a meta-analysis of four RCTs, when TTM was initiated 
in the prehospital setting using cold crystalloid intravenous fluid 
infusion, the risk for re-arrest increased.46 In addition, pulmonary 
edema was increased according to one large-scale RCT.58 There-
fore, it is not recommended to perform routine prehospital cool-
ing of a patient after ROSC with the rapid infusion of cold intra-
venous fluid.
 When TTM is performed, the patient’s core temperature should 
be continuously monitored in the esophagus, bladder, or pulmo-
nary artery. The pulmonary artery is the most accurate, but it has 
a limitation because it requires an invasive procedure. The axillary 
temperature or oral temperature is not appropriate for measuring 
changes in the core temperature, and tympanic temperature sen-
sors are difficult to use for a long time and they are often inac-
curate. The rectal temperature is commonly used, but there can 
be temperature gaps when hypothermia is induced rapidly; thus, 
careful monitoring is needed.61
 Moreover, there is not enough evidence for an optimal speed 
of rewarming. Accordingly, it is suggested to rewarm at a speed 
of 0.25°C to 0.5°C per hour, which has been used often in previ-
ous studies,41,42,48 and maintain normothermia (36.5°C to 37.5°C) 
up to 72 hours after ROSC in comatose patients even after nor-
mothermia is achieved.
2. Glucose control
Hyperglycemia is associated with mortality and a poor neurologic 
outcome in patients who have been resuscitated from cardiac ar-
rest, and it should be appropriately controlled. There is little evi-
dence about a target blood glucose level to improve the outcome 
of patients with cardiac arrest. An RCT found no difference in the 
30-day mortality rate between the groups with a target blood 
glucose level of 72 to 108 mg/dL and 108 to 144 mg/dL.62 In a 
before-and-after study that used a bundle of care with a target 
blood glucose level of 90 to 144 mg/dL, the neurological outcome 
improved after implementing the bundle, but the effect could not 
be attributed only to the controlled blood glucose level.18 Apply-
ing the findings of these studies to cardiac arrest patients may 
not be appropriate, because they examined the effect of control-
ling blood glucose level in critically ill patients.63,64 Although is 
still controversy on how to control the blood glucose level in crit-
ically ill patients, the strict control of blood glucose was associat-
ed with an increased occurrence of hypoglycemia.62 Therefore, 
the target range of 144 to 180 mmHg is suggested to prevent 
hypoglycemia, although evidence so far is insufficient. Hypergly-
cemia >180 mmHg should be treated with an insulin infusion 
per the hospital’s protocol, and care should be taken to prevent 
hypoglycemia (<80 mg/dL). If hypoglycemia occurs, it should be 
immediately corrected by administering a glucose solution. The 
blood glucose level, especially, fluctuates during the induction or 
rewarming period; therefore, it is desirable to frequently test the 
patient’s blood glucose level.
 
3. Control of seizures
No study has directly compared patients treated for seizure with 
those not treated for seizure. Furthermore, there is no evidence 
thus far that a specific anticonvulsant or combination therapy 
with anticonvulsant drugs is helpful in comatose patients after 
cardiac arrest. Therefore, if seizure occurs or is suspected, an elec-
troencephalogram (EEG) needs to be performed immediately to 
determine the presence of epileptiform activity. Non-convulsive 
seizures can occur while TTM is performed with a neuromuscular 
blocking drug; thus, if possible, an EEG should be continuously 
monitored, and the arterial blood gas level or change in vital signs 
(e.g., unexplained tachycardia) should be carefully observed.65 To 
control seizures, any commonly used anticonvulsant needs to be 
promptly injected. In a case of generalized seizure, benzodiaze-
pine, phenytoin, sodium valproate, propofol, levetiracetam, phe-
nobarbital, and similar drugs can be used alone or in combination 
with each other. In cases of myoclonus, clonazepam, sodium val-
proate, levetiracetam, propofol, etc. can be used alone or in com-
bination with each other.66 Post-anoxic myoclonic status epilepti-
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cus may not respond well to anticonvulsants.67,68 Available evi-
dence does not support the prophylactic administration of anti-
convulsants. Therefore, the routine use of prophylactic anticon-
vulsants in post-cardiac arrest patients is not recommended.
4. Sedation
In most post-cardiac arrest patients, mechanical ventilation should 
be maintained during post-cardiac arrest care, and sedatives or 
analgesics may have to be intermittently or continuously admin-
istered. If a patient is sedated while TTM is performed, the time 
required to reach to the target temperature can be reduced be-
cause shivering is prevented or reduced. Using a sedation proto-
col can be helpful in these cases.
 Sedation after ROSC is a commonly used treatment method, 
but the level of evidence is not sufficient to make a recommen-
dation about the duration to administer a sedative or neuromus-
cular blocker in post-cardiac arrest patients. A meta-analysis of 
44 studies reported on sedative drugs that were used while TTM 
was performed among 68 intensive care units in various coun-
tries found that a large variety of drugs were being used.69 From 
the analysis, it is impossible to know which drugs may be associ-
ated with outcome, but mainly the combination therapy of an 
opioid and sedative was used. It is recommended to maintain a 
sedative over a short duration of action as much as possible, but 
no study has analyzed the effect of using sedatives in patients 
after cardiac arrest or has suggested treatment strategies. One 
study has suggested that the continuous administration of neu-
romuscular blockers may be associated with a low mortality rate.70 
However, neuromuscular blockers interfere with clinical examina-
tions, and they obscure the occurrence of seizure. Therefore, if a 
neuromuscular blocker is continuously administered, the EEG should 
be continuously monitored.
EVALUATION OF NEUROLOGICAL  
PROGNOSTICATION
In the 2015 guidelines, studies of patients who had and had not 
received TTM were evaluated. These studies evaluated the diag-
nostic accuracy of clinical examination, electrophysiological stud-
ies, biomarkers, and imaging tests for predicting poor neurologi-
cal outcome, and they recommended diagnostic tests with a false 
positive rate (FPR) close to 0% and a narrow 95% confidence in-
terval (0% to 10%) as predictors.
 It is recommended to predict the neurologic outcome at least 
72 hours after ROSC, particularly because in most cases, a seda-
tive and a neuromuscular blocker are administered to comatose 
patients after cardiac arrest while TTM is performed. An addition-
al recommendation is to use a multimodal approach rather than 
relying on a single test or finding.
1. Clinical examination
For a clinical examination to predict a poor neurologic outcome 
within 72 hours after ROSC in comatose patients after cardiac 
arrest, the bilateral absence of pupillary light reflex, or the com-
bination of the absence of pupillary light reflex and absence of 
corneal reflex is required in both patients with TTM (FPR 0 [0% to 
3%]) and without TTM (FPR 0 [0% to 8%]).71-79
 The lack of motor movement (M1) or extensor posturing (M2) 
to pain has a high FPR level (27% [12% to 48%]) for predicting a 
poor neurologic outcome in comatose patients who did not re-
ceive TTM after cardiac arrest, and a similar finding was observed 
in patients who received TTM.71,73-82 Therefore, it is suggested to 
not use motor movement to pain alone to predict poor neurologic 
outcomes. Although they have a high sensitivity level (74% [68% 
to 79%]), they can be used to confirm a patient’s poor neurologic 
outcome or predict a poor neurologic outcome in combination 
with other predictors.
 Myoclonus in comatose patients within 72 hours after cardiac 
arrest is associated with a high FPR (10% to 15%) for predicting 
poor neurologic outcomes; thus, it is suggested to not use it alone. 
In contrast, status myoclonus, which occurs within 72 hours after 
cardiac arrest, predicts poor neurologic outcome with a high ac-
curacy in cases with TTM (FPR 0% [0% to 4%]) and without TTM 
(FPR 0% [0% to 5%]).65,67,71,72,83,84 Therefore, it is useful when used 
in combination with other predictors. If there is residual sedation 
and paralysis still remains, the clinical examination can be de-
layed to minimize the possibility of false positives. Seventy-two 
hours after ROSC is suggested as the earliest time to predict a 
poor neurologic outcome.
2. Electrophysiological studies
To predict poor neurologic outcome in comatose patients after 
cardiac arrest, regardless of using TTM, the use of the bilateral 
absence of N20 waveform recorded from somatosensory evoked 
potentials (SSEPs) (FPR 1% [0% to 3%]) is recommended 24 to 
72 hours after cardiac arrest or after rewarming.72-75,80-82,85-89 An 
SSEP recording requires appropriate skills and experience, and ef-
forts should be considered to avoid muscle artifacts or electrical 
interference from the environment of the emergency room or in-
tensive care unit.
 A lack of EEG background reactivity can accurately predict 
poor neurologic outcome in comatose patients after cardiac ar-
rest during TTM (FPR 2% [1% to 7%]) and within 72 hours after 
ROSC (FPR 0% [0% to 3%]).80,82,90,91 However, using the pattern 
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of background reactivity on EEG has limitations, because they are 
operator dependent, unquantifiable, and lack standardization. 
Status epilepticus (i.e., a persistent seizure over 72 hours) is com-
monly associated with a poor neurologic outcome (FPR 0% to 
6%), if it occurs during hypothermia or rewarming in patients 
who received TTM.65,92 EEG burst-suppression can show a recov-
ery of consciousness, if it occurs for 24 to 48 hours after ROSC in 
patients who did not receive TTM, or during hypothermia in pa-
tients who received TTM,82,93 but persistent burst-suppression 
that occurs 72 hours after ROSC is always associated with a poor 
neurologic outcome.72,94 Therefore, it is suggested to use EEG pre-
dictors (e.g., the lack of EEG response to external stimulation, EEG 
burst-suppression after rewarming, and status epilepticus) after 
72 hours after ROSC in combination with other predictors to pre-
dict a poor neurologic outcome in comatose patients after cardi-
ac arrest, regardless of using TTM.
 To predict poor neurologic outcomes of patients who received 
TTM, burst-suppression observed in the continuous amplitude-in-
tegrated EEG recordings, status epilepticus, and lack of normal 
trace over 36 hours can be used in combination with other pre-
dictors.95
3. Biomarkers
A high level or increasing levels of neuron-specific enolase (NSE) 
measured at 48-72 hours after ROSC can be used in combination 
with other predictors to predict poor neurologic outcomes of co-
matose patients who received TTM after cardiac arrest.96-98 A care-
ful approach is necessary when testing NSE to avoid a false posi-
tive result that can occur due to hemolysis, and it is recommend-
ed to sample various points in time as much as possible. Since 
different studies have reported different NSE thresholds to predict 
a poor neurologic outcome with 0% FPR, it is recommended to 
not use the serum levels of NSE and S100B alone.
Fig. 2. Neurological prognostication algorithm. N/Ex, neurological examination; CT, computed tomography; NSE, neuron specific enolase; SSEP, somato-
sensory evoked potential; DW-MRI, diffusion-weighted magnetic resonance imaging; EEG, electroencephalography; ROSC, return of spontaneous circu-
lation; GWR, gray matter/white matter ratio; CT, computed tomography; aEEG, amplitude-integrated electroencephalography.
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Presence of 1, 2, and 3?
Wait  
at least  
24 hours
Observe and re-evaluate
Two or more of the following:
∙  Marked reduction in the GWR on brain CT obtained within 2 hours
∙ No normal trace on aEEG ≤36 hours after ROSC
∙ Status myoclonus ≤72 hours after ROSC
∙ High NSE level at 48-72 hours after ROSC
∙  Unreactive, burst suppression, or status epilepticus on EEG ≥72 
hours after ROSC
∙  Extensive restriction of diffusion on brain DW-MRI at 2 to 6 days 
after ROSC
No
No
Yes
Yes
Poor outcome 
very likely
Day 2 Day 3 Day 4 Day 5 Day 6 Day 7
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ROSC. A poor neurologic outcome can be predicted if two of six 
factors are observed. Otherwise, the outcome can be determined 
based on various findings in combination or after additional ob-
servation.
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